The global Pompe Disease market size reached USD 1,386.09 Million in 2021 and is expected to register a revenue CAGR of 3.9% during the forecast period, according to a latest analysis by Emergen Research. Increasing prevalence of Pompe Disease, rising number of clinical studies and trials in the field of Pompe-disease-based treatments, and introduction of novel and advanced screening platforms for early diagnosis are crucial factors driving market revenue growth.
Pompe disease is a hereditary, frequently fatal ailment that affects the heart and skeletal muscles. It is thought to affect one in every 40,000 births, according to the National Institute of Neurological Disorders and Stroke. Mutations in a gene that produces an enzyme called acid alpha-glucosidase cause it (GAA). Many researchers are trying to better understand the earliest features and manifestations of late-onset Pompe disease novel screening platforms such as newborn screening.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/1081
According to the Muscular Dystrophy Association (MDA), 20 states are now testit newborns through newborn screening platforms for Pompe Disease, the latest neuromuscular disease, which is being added to a list of significant genetic disorders for which children can be tested shortly after delivery in the United States. We are investigating if starting people early on the right dose of ERT could impact outcomes. Targeted screening of at-risk individuals, as well as general newborn screening, can lead to early detection and treatment of Pompe disease patients, potentially improving clinical outcomes. Other advanced and creative diagnostic systems, such as enzyme activity assessment using a tandem-mass-spectrometry-based assay for Pompe disease, are being produced, examined, and validated in large screening programs.
The Global Pompe Disease Market Research Report added to its expanding repository is an all-inclusive document containing insightful data about the Pompe Disease market and its key elements. The report is formulated through extensive primary and secondary research and is curated with an intent to offer the readers and businesses a competitive edge over other players in the industry. The report sheds light on the minute details of the Pompe Disease industry pertaining to growth factors, opportunities and lucrative business prospects, regions showing promising growth, and forecast estimation till 2030.
To know more about the report @ https://www.emergenresearch.com/industry-report/pompe-disease-market
Emergen Research has segmented global Pompe Disease market on the basis of type, treatment type, end-use and region:
Type Outlook (Revenue, USD Million; 2019-2030)
Infantile-Onset Pompe Disease (IOPD)
Late-Onset Pompe Disease (LOPD)
Treatment Type Outlook (Revenue, USD Million; 2019-2030)
Enzyme Replacement Therapy (ERT)
Chaperone Therapy
Substrate Replacement Therapy (SRT)
Others
End-Use Outlook (Revenue, USD Million; 2019-2030)
Hospitals
Diagnostic Centers
Others
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Pompe Disease market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
Key players include
Sanofi S.A.,
Amicus Therapeutics, Inc.,
BioMarin Pharmaceutical,
Valerion Therapeutics,
Oxyrane,
Genzyme Corporation,
EpiVax, Inc.,
Bayer AG,
Audentes Therapeutics, and
Sangamo Therapeutics
Request a discount on the report @ https://www.emergenresearch.com/request-discount/1081
Regional Segmentation
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Highlights of Table of Contents (TOC):
Overview of Global Pompe Disease Market
Competitive analysis of the Pompe Disease market
Regional analysis of Global Pompe Disease market production and revenue
Regional analysis of Global Pompe Disease market supply, consumption, and export & import
Type-based market analysis of global Pompe Disease production, revenue, and price trends
Application-based analysis of the global Pompe Disease market
Manufacturer profiles, manufacturing cost, and upstream and downstream analysis of global Pompe Disease market
Global Pompe Disease market forecast (2022-2030)
Conclusion of the research report
Appendix
Request a customization of the report @ https://www.emergenresearch.com/request-for-customization/1081
Thank you for reading the research report. To get more information about the customized report and customization plan, kindly connect to us and we will provide you with the well-suited customized report.
Take a Look at our other Reports:
In-Situ Hybridization Market
Interventional Cardiology Devices Market
Laboratory Centrifuges Market
Nanotechnology Market
Near-Infrared Imaging Market
Orthopedic Biomaterial Market
RNA Transcriptomics Market
About Us:
At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release @ https://www.emergenresearch.com/press-release/global-pompe-disease-market